公众号 / 文章消化、代谢与肾脏急症重症综合管理与镇静镇痛

慢性髓性白血病患者自发性肿瘤溶解综合征经别嘌醇治疗成功

Spontaneous tumor lysis syndrome in a patient with chronic myeloid leukemia treated successfully with allopurinol.
PubMed 文献 · Am J Emerg Med · 2023-11-10
一句话结论慢性髓性白血病慢性期患者可发生自发性肿瘤溶解综合征,经积极静脉水化、别嘌醇、羟基脲和伊马替尼治疗后48小时内肌酐和尿酸改善。

本文报告一例67岁牙买加女性,有高血压病史,因腹痛、恶心、呕吐1天就诊急诊科,发现白细胞增多至344,000(4%原始细胞)、高尿酸血症和急性肾损伤。外周血涂片确诊慢性髓性白血病(CML),骨髓活检证实为慢性期,患者符合自发性肿瘤溶解综合征的临床标准。给予积极静脉水化、别嘌醇、羟基脲和伊马替尼治疗,启动该方案后48小时内肌酐和尿酸水平改善。作者指出,基于TLS风险分层CML为低危疾病,据其所知,CML慢性期自发性TLS经别嘌醇和积极水化成功治疗尚未见文献报道。

要点

  • CML慢性期基于TLS风险分层为低危疾病,但仍可发生自发性TLS,即使尚未开始化疗。
  • 67岁女性CML慢性期患者因腹痛、恶心、呕吐1天就诊,白细胞344,000(4%原始细胞)、高尿酸血症和急性肾损伤,符合自发性TLS临床标准。
  • 治疗采用积极静脉水化、别嘌醇、羟基脲和伊马替尼,启动后48小时内肌酐和尿酸水平改善。
  • 自发性TLS主要见于急性白血病和非霍奇金淋巴瘤,CML慢性期自发性TLS罕见,据作者所知尚未见经别嘌醇和积极水化成功治疗的文献报道。

适用人群与场景

  • 67岁牙买加女性,有高血压病史,因腹痛、恶心、呕吐1天至急诊科就诊。
  • 外周血涂片确诊CML,骨髓活检证实为慢性期。

诊断标准与关键阈值

  • 患者符合自发性肿瘤溶解综合征的临床标准。

处置流程与药物剂量

  • 给予积极静脉水化、别嘌醇、羟基脲和伊马替尼治疗。
  • 启动该方案后48小时内肌酐和尿酸水平改善。

研究设计与关键结果

  • 病例报告:67岁女性CML慢性期患者发生自发性TLS,经积极静脉水化、别嘌醇、羟基脲和伊马替尼治疗后48小时内肌酐和尿酸改善。

证据类型、等级与局限

  • 证据类型:病例报告。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者指出,基于TLS风险分层CML为低危疾病,但CML慢性期仍可发生自发性TLS;据作者所知,CML慢性期自发性TLS经别嘌醇和积极水化成功治疗尚未见文献报道。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Tumor Lysis Syndrome (TLS) is an oncologic emergency that may occur in any patient with a hematologic malignancy, even prior to initiation of chemotherapy. Spontaneous TLS massive tumor cell destruction with intracellular electrolyte release prior to the initiation of chemotherapy. Spontaneous tumor lysis syndrome is a rare presentation, mainly occurring in Acute Leukemia and non-Hodgkin Lymphoma. Chronic Myeloid Leukemia (CML) is a low-risk disease based on TLS risk stratification. To the best of our knowledge, spontaneous TLS in the chronic phase of CML successfully treated with allopurinol and aggressive hydration has yet to be reported in the literature. A case report is described regarding a 67 year old Jamaican female with a history of hypertension who presented to the emergency department with abdominal pain, nausea, and vomiting for 1 day. The patient was found to have leukocytosis to 344,000 with 4% Blasts, hyperuricemia, and acute kidney injury. A peripheral blood smear confirmed the diagnosis of CML. Bone marrow biopsy was performed with evidence of the chronic phase of CML. The patient met clinical criteria for spontaneous tumor lysis syndrome. The patient was started on aggressive intravenous hydration, allopurinol, hydroxyurea and imatinib. Creatinine and uric acid level improved on this regimen within 48 h of initiation.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Gartenberg A, Winkel M, Leonard N, et al. Spontaneous tumor lysis syndrome in a patient with chronic myeloid leukemia treated successfully with allopurinol. Am J Emerg Med. 2023. PMID: 38007380. doi:10.1016/j.ajem.2023.11.010

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。